Status: current, Primitive. Date: 30-Nov 2017. Module: Australian Medicines Terminology module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 2151211000168110 | Hyoscine Butylbromide (SXP) (trade product) | en | Fully specified name | Active | Case sensitive | Australian Medicines Terminology module |
| 2151221000168115 | Hyoscine Butylbromide (SXP) | en | Synonym | Active | Case sensitive | Australian Medicines Terminology module |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Hyoscine Butylbromide (SXP) | Is a | trade product | true | Inferred relationship | Some |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Hyoscine Butylbromide (SXP) 20 mg/mL injection, ampoule | Is a | True | Hyoscine Butylbromide (SXP) | Inferred relationship | Some | |
| Hyoscine Butylbromide (SXP) 20 mg/mL injection, 5 x 1 mL ampoules | has TP | True | Hyoscine Butylbromide (SXP) | Inferred relationship | Some | |
| Hyoscine Butylbromide (SXP) 20 mg/mL injection, 10 x 1 mL ampoules | has TP | True | Hyoscine Butylbromide (SXP) | Inferred relationship | Some | |
| Hyoscine Butylbromide (SXP) 20 mg/mL injection, 5 x 1 mL ampoules | has TP | True | Hyoscine Butylbromide (SXP) | Inferred relationship | Some | |
| Hyoscine Butylbromide (SXP) 20 mg/mL injection, 10 x 1 mL ampoules | has TP | True | Hyoscine Butylbromide (SXP) | Inferred relationship | Some |
Reference Sets
Australian dialect reference set
FHIR